We are grateful for the opportunity to reply to Dr. David Savitz's comments (1) on the findings of our study (2) . Of necessity, we will concentrate on certain points, omitting others equally worthy of discussion.
Dr. Savitz outlines, with admirable clarity, an ideal epidemiologic study of the health effects of electromagnetic field (EMF) exposures. By such exacting standards, any real-life study is bound to fail, and the interesting question is how and to what extent. We believe that studies of railway personnel permit epidemiologists to get close to Dr. Savitz Dr. Savitz argues that the weak point of EMF research is the lack of a biologically plausible pathway. A review of the literature has convinced us otherwise. There is extensive evidence linking extremely low frequency EMF exposure to calcium ion concentrations (3-6), apoptosis (7), melatonin levels (8, 9), chromosome damage, and cancer (see discussion below). There is also evidence linking calcium ion balance to apoptosis (10), melatonin levels (11), chromosome damage, and cancer. For brevity, we shall restrict ourselves here to the evidence on chromosome damage, a precursor of (14) have all found elevated levels of chromosome damage among workers exposed to extremely low frequency EMFs. Nordenson et al. (15, 16) , Rosenthal and Obe (17) , Khalil and Qassem (18) , and Garcia-Sagredo and Monteagudo (19) have found elevated levels of chromosome damage in human cell lines after exposure to extremely low frequency EMFs. El Nahas and Oraby (20) found an extremely low frequency EMF dose-dependent increase in micronuclei of mouse somatic cells.
This biologic evidence, combined with the ample epidemiologic evidence of dose-response relations between leukemia and extremely low frequency EMF exposure, seems to us to satisfy Hill's criteria for causality (21) . Thus, Dr. Savitz's suggestion of "a possible modest association" (1, p. 838) could be misinterpreted. The risk ratios found for leukemia and extremely low frequency EMF exposure are similar in magnitude to those for lung cancer and passive smoking. Both of these associations may be modest in size; in our opinion, both are well established. The research cited above suggests that the association between extremely low frequency EMFs and leukemia may be causal. If this is the case, its public health impact will not be modest.
We agree with Dr. Savitz that "black box" epidemiology has made its contribution to solving this problem. We feel that now is the time to impartially assemble all of the available evidence on the biology and health effects of extremely low frequency EMF exposure. It would be fitting for the Society for Epidemiologic Research to initiate such an effort.
